← FDA Drug Approvals (Drugs@FDA)
SOFOSBUVIR
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2022-01-27
Drug application
- FDA Application #
ANDA211353- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SOFOSBUVIR
- Generic name
- Sofosbuvir
- Active ingredients
- SOFOSBUVIR
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS USA INC
- First approval
- 2022-01-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown